Do innovative new drugs require high prices to offset the cost and risk of R&D? Or, could the prices of new drugs be substantially reduced without reducing the yield of clinically valuable new medicines? Pharma companies and critics need to work together to find new ways to make medicines that are both innovative and affordable.

This panel will bring together experts from industry and academia to wrestle with key questions about the tradeoffs between drug prices, R&D costs and pharmaceutical innovation: What are the key drivers of the cost, risk and value of drug R&D, and how can we impact them? What is the relationship between drug prices and innovative pharmaceutical R&D?

Ability Level: All

Session ID: 19781